Related Experiment Video
Updated: Feb 12, 2026

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Tubulointerstitial Biomarkers for Diabetic Nephropathy
1Division of Nephrology, Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
Diabetic nephropathy patients need better biomarkers. Novel markers like KIM-1 and NGAL show promise for detecting kidney injury and predicting outcomes in type 2 diabetes.
Area of Science:
- Nephrology
- Endocrinology
- Biomarker Discovery
Background:
- Diabetic nephropathy increases mortality risk, primarily from cardiovascular issues.
- Current biomarkers (serum creatinine, eGFR, albuminuria) lack precision and sensitivity for early renal injury detection.
- There is a critical need for novel biomarkers to accurately assess kidney function and prognosis in diabetic nephropathy.
Purpose of the Study:
- To review the potential applications of novel biomarkers in managing diabetic nephropathy.
- To highlight biomarkers reflecting tubular injury for improved renal progression prediction.
- To discuss biomarkers initially identified in acute kidney injury for chronic kidney disease evaluation.
Main Methods:
- Literature review focusing on novel biomarkers for diabetic nephropathy.
- Analysis of biomarkers reflecting tubulointerstitial changes and tubular injury.
- Inclusion of biomarkers such as cystatin C, KIM-1, NGAL, angiotensinogen, periostin, and MCP-1.
Main Results:
- Novel biomarkers, including KIM-1 and NGAL, show potential in evaluating chronic kidney disease.
- These biomarkers reflect tubular injury, offering a more direct measure of renal damage.
- Their application in diabetic nephropathy may improve the prediction of renal progression and patient outcomes.
Conclusions:
- Novel biomarkers offer enhanced sensitivity and specificity for detecting kidney injury in diabetic nephropathy.
- Biomarkers reflecting tubular injury hold significant promise for predicting disease progression and prognosis.
- Further research into these novel markers is crucial for clinical application in type 2 diabetes management.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

